Colgate-Palmolive outshines peers

• Colgate-Palmolive (NYSE:CL) is higher in early action after topping Q4 estimates.
• Global volume was up 2.5% during the period.
• Organic sales in emerging markets rose 9.5% Y/Y and 6% overall.
• The pace of organic sales growth topped Procter & Gamble and Kimberly-Clark for a roughly overlapping period.
• The company cut its forecast for 2015 EPS growth to a low single-digit rate on F/X concerns in a widely anticipated action.
• Previously: Colgate-Palmolive beats by $0.02, misses on revenue
• CL +5.2% premarket.